Revenue Growth Benchmark
Innovator Drug Sales Dashboard
In 2022, global sales reached approximately $1.5 trillion. Our platform highlights over 500 innovator drugs, contributing to a market value of nearly $650 billion.
The leading therapy areas for innovative drugs were oncology, anti-virals, and immunology, which together made up 60% of worldwide sales in 2022. Anti-virals saw particularly significant sales growth, with a CAGR of 29%, largely driven by the increased demand for COVID-19 treatments. By contrast, oncology and immunology grew at CAGRs of 12% and 10%, respectively.
For a deeper understanding, you can explore extensive five-year sales data from leading global pharmaceutical companies, meticulously organized by therapy areas.
Talk To Us
We will connect you to the right professional within our Healthcare Research & Advisory Team
About Us
Services
Knowledge Library
Contact Us
© , Aranca. All rights reserved.
United States | United Kingdom | China | India | Dubai | KSA | Japan